🇯🇵 Prevnar 20 in Japan
Prevnar 20 (pneumococcal 20-valent conjugate vaccine (PCV20)) regulatory status in Japan.
Pricing & reimbursement
- Net: JPY 110.00 per year
- Net: JPY 110.00 per year
- Net: JPY 110.00 per year
- Net: JPY 110.00 per year
- Net: JPY 110.00 per year
Prevnar 20 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Prevnar 20 approved in Japan?
Prevnar 20 does not currently have Japanese marketing authorisation in our dataset.
Who is the marketing authorisation holder for Prevnar 20 in Japan?
Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.
What does Prevnar 20 cost in Japan?
Net: JPY 110.00 per year; Net: JPY 110.00 per year; Net: JPY 110.00 per year; Net: JPY 110.00 per year; Net: JPY 110.00 per year. Final patient cost depends on reimbursement and any patient access scheme.